{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:34:00Z","timestamp":1779338040633,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.omtm.2020.12.009","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T05:43:40Z","timestamp":1608875020000},"page":"389-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-2053","authenticated-orcid":false,"given":"Ilana","family":"Moscatelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-3455","authenticated-orcid":false,"given":"Elena","family":"Almarza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ricks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansgar","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Askmyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.12.009_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbrc.2006.02.147","article-title":"Osteoclast and its roles in calcium metabolism and bone development and remodeling","volume":"343","author":"Li","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2020.12.009_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/156652309788488613","article-title":"Prospects for gene therapy of osteopetrosis","volume":"9","author":"Askmyr","year":"2009","journal-title":"Curr. Gene Ther."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2020.12.009_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1034\/j.1399-3046.1999.00063.x","article-title":"Human malignant osteopetrosis: pathophysiology, management and the role of bone marrow transplantation","volume":"3","author":"Fasth","year":"1999","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.omtm.2020.12.009_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajh.21447","article-title":"A single-center experience in 20 patients with infantile malignant osteopetrosis","volume":"84","author":"Mazzolari","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.omtm.2020.12.009_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1542\/peds.93.2.247","article-title":"Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course","volume":"93","author":"Gerritsen","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2020.12.009_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fendo.2019.00085","article-title":"One disease, many genes: Implications for the treatment of osteopetroses","volume":"10","author":"Penna","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.omtm.2020.12.009_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-4-5","article-title":"Osteopetrosis","volume":"4","author":"Stark","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2020.12.009_bib8","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/hmg\/10.17.1767","article-title":"The mutational spectrum of human malignant autosomal recessive osteopetrosis","volume":"10","author":"Sobacchi","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.12.009_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/77131","article-title":"Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis","volume":"25","author":"Frattini","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2020.12.009_bib10","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1359\/jbmr.2003.18.10.1740","article-title":"Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis","volume":"18","author":"Frattini","year":"2003","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.12.009_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/geno.1999.5751","article-title":"Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T\u00a0cell activation","volume":"57","author":"Heinemann","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.omtm.2020.12.009_bib12","doi-asserted-by":"crossref","first-page":"18636","DOI":"10.1074\/jbc.272.30.18636","article-title":"Characterization of the osteoclast ruffled border chloride channel and its role in bone resorption","volume":"272","author":"Schlesinger","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.12.009_bib13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1126\/science.2528207","article-title":"Osteoclastic bone resorption by a polarized vacuolar proton pump","volume":"245","author":"Blair","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.12.009_bib14","doi-asserted-by":"crossref","first-page":"24979","DOI":"10.1016\/S0021-9258(17)31485-0","article-title":"Isolation and reconstitution of a vacuolar-type proton pump of osteoclast membranes","volume":"269","author":"Mattsson","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2020.12.009_bib15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.omtm.2020.12.009_bib16","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(86)90477-0","article-title":"Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985","volume":"2","author":"Fischer","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2020.12.009_bib17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(05)82004-9","article-title":"Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group","volume":"125","author":"Gerritsen","year":"1994","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.omtm.2020.12.009_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1704194","article-title":"Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report","volume":"32","author":"Driessen","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omtm.2020.12.009_bib19","first-page":"667","article-title":"Osteopetrosis. Consensus guidelines for diagnosis, therapy and follow-up","volume":"19","author":"Schulz","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.omtm.2020.12.009_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2015-01-625541","article-title":"Hematopoietic stem cell transplantation for infantile osteopetrosis","volume":"126","author":"Orchard","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.12.009_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.12.009_bib22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa012616","article-title":"Sustained correction of X-linked severe combined immunodeficiency by ex\u00a0vivo gene therapy","volume":"346","author":"Hacein-Bey-Abina","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib23","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2020.12.009_bib24","doi-asserted-by":"crossref","first-page":"97ra79","DOI":"10.1126\/scitranslmed.3002715","article-title":"Long-term persistence of a polyclonal T\u00a0cell repertoire after gene therapy for X-linked severe combined immunodeficiency","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib25","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.12.009_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib27","doi-asserted-by":"crossref","first-page":"97ra80","DOI":"10.1126\/scitranslmed.3002716","article-title":"Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib29","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/mt.2011.166","article-title":"Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I\/II trial","volume":"19","author":"Kang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib30","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome","volume":"363","author":"Boztug","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib31","doi-asserted-by":"crossref","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity","volume":"6","author":"Braun","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T\u00a0cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.12.009_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib34","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.12.009_bib35","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.12.009_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib37","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/ACI.0000000000000114","article-title":"Progress in gene therapy for primary immunodeficiencies using lentiviral vectors","volume":"14","author":"Sauer","year":"2014","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.omtm.2020.12.009_bib38","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2004-03-0798","article-title":"Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells","volume":"105","author":"De Palma","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.12.009_bib39","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","article-title":"A modified \u03b3-retrovirus vector for X-linked severe combined immunodeficiency","volume":"371","author":"Hacein-Bey-Abina","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1089\/hum.2012.229","article-title":"Biosafety features of lentiviral vectors","volume":"24","author":"Schambach","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib41","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.12.009_bib42","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","article-title":"Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection","volume":"117","author":"Biffi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.12.009_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molmed.2016.02.002","article-title":"Treating Immunodeficiency through HSC Gene Therapy","volume":"22","author":"Booth","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib44","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.omtm.2020.12.009_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/hum.2016.007","article-title":"Gene Therapy of the \u03b2-Hemoglobinopathies by Lentiviral Transfer of the \u03b2(A(T87Q))-Globin Gene","volume":"27","author":"Negre","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib46","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene Therapy in a Patient with Sickle Cell Disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fped.2019.00443","article-title":"Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives","volume":"7","author":"Staal","year":"2019","journal-title":"Front Pediatr."},{"key":"10.1016\/j.omtm.2020.12.009_bib48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/156652308784049381","article-title":"Human hematopoietic stem cells in gene therapy: pre-clinical and clinical issues","volume":"8","author":"Biffi","year":"2008","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbmt.2004.11.001","article-title":"High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis","volume":"11","author":"Steward","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2020.12.009_bib50","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2019.238261","article-title":"Expanded circulating hematopoietic stem\/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis","author":"Capo","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2020.12.009_bib51","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/jbmr.90","article-title":"Nonablative neonatal bone marrow transplantation rapidly reverses severe murine osteopetrosis despite low-level engraftment and lack of selective expansion of the osteoclastic lineage","volume":"25","author":"Flores","year":"2010","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.12.009_bib52","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00223-016-0187-6","article-title":"Regulation and Function of Lentiviral Vector-Mediated TCIRG1 Expression in Osteoclasts from Patients with Infantile Malignant Osteopetrosis: Implications for Gene Therapy","volume":"99","author":"Thudium","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.omtm.2020.12.009_bib53","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1089\/hum.2017.053","article-title":"Targeting NSG Mice Engrafting Cells with a Clinically Applicable Lentiviral Vector Corrects Osteoclasts in Infantile Malignant Osteopetrosis","volume":"29","author":"Moscatelli","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib54","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0002-9440(10)63712-1","article-title":"Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II","volume":"164","author":"Henriksen","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2020.12.009_bib55","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0002-9440(10)61221-7","article-title":"Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in\u00a0vitro, but have decreased resorption capacity in\u00a0vivo","volume":"167","author":"Henriksen","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2020.12.009_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2013.07.026","article-title":"Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosis","volume":"57","author":"Moscatelli","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.omtm.2020.12.009_bib57","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1359\/JBMR.040302","article-title":"The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation","volume":"19","author":"Schaller","year":"2004","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.12.009_bib58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1359\/JBMR.050905","article-title":"Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification","volume":"21","author":"Henriksen","year":"2006","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.12.009_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00774-006-0725-9","article-title":"Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood","volume":"25","author":"S\u00f8rensen","year":"2007","journal-title":"J.\u00a0Bone Miner. Metab."},{"key":"10.1016\/j.omtm.2020.12.009_bib60","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1359\/jbmr.070613","article-title":"Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption","volume":"22","author":"S\u00f8rensen","year":"2007","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.12.009_bib61","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/jbmr.113","article-title":"Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycle","volume":"25","author":"S\u00f8e","year":"2010","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.12.009_bib62","doi-asserted-by":"crossref","first-page":"e71098","DOI":"10.1371\/journal.pone.0071098","article-title":"Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions","volume":"8","author":"van Wilgenburg","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.12.009_bib63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13287-020-01701-y","article-title":"Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells","volume":"11","author":"Xian","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib64","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2106\/JBJS.19.00558","article-title":"TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis","volume":"101","author":"Chen","year":"2019","journal-title":"J.\u00a0Bone Joint Surg. Am."},{"key":"10.1016\/j.omtm.2020.12.009_bib65","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.stemcr.2015.08.005","article-title":"Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts","volume":"5","author":"Neri","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.omtm.2020.12.009_bib66","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41586-019-1105-7","article-title":"Developmental origin, functional maintenance and genetic rescue of osteoclasts","volume":"568","author":"Jacome-Galarza","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2020.12.009_bib67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1359\/jbmr.090715","article-title":"Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis","volume":"25","author":"Cappariello","year":"2010","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.omtm.2020.12.009_bib68","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S8756-3282(99)00278-1","article-title":"The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc\/oc) mutants","volume":"26","author":"Scimeca","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.omtm.2020.12.009_bib69","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/sj.leu.2403449","article-title":"Hematological defects in the oc\/oc mouse, a model of infantile malignant osteopetrosis","volume":"18","author":"Blin-Wakkach","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.omtm.2020.12.009_bib70","doi-asserted-by":"crossref","first-page":"100242","DOI":"10.1016\/j.bonr.2020.100242","article-title":"Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosis","volume":"12","author":"Palagano","year":"2020","journal-title":"Bone Rep."},{"key":"10.1016\/j.omtm.2020.12.009_bib71","doi-asserted-by":"crossref","first-page":"14629","DOI":"10.1073\/pnas.0507637102","article-title":"Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero","volume":"102","author":"Frattini","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.12.009_bib72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.exphem.2005.11.010","article-title":"Neonatal hematopoietic stem cell transplantation cures oc\/oc mice from osteopetrosis","volume":"34","author":"Johansson","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.omtm.2020.12.009_bib73","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1182\/blood-2006-12-061382","article-title":"Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc\/oc mice","volume":"109","author":"Johansson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.12.009_bib74","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mt.2008.5","article-title":"Physiological promoters reduce the genotoxic risk of integrating gene vectors","volume":"16","author":"Zychlinski","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib75","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/mt.2013.265","article-title":"Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency","volume":"22","author":"Carbonaro","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib76","doi-asserted-by":"crossref","first-page":"335ra57","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2020.12.009_bib77","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mt.2010.226","article-title":"Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells","volume":"19","author":"Santilli","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib78","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1089\/hum.2019.047","article-title":"Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in oc\/oc Mice","volume":"30","author":"L\u00f6fvall","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.12.009_bib79","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2009-10-250209","article-title":"A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T\u00a0cells","volume":"116","author":"Zhou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2020.12.009_bib80","doi-asserted-by":"crossref","first-page":"e62333","DOI":"10.1371\/journal.pone.0062333","article-title":"Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2020.12.009_bib81","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/hum.2016.103","article-title":"The Role of Conditioning in Hematopoietic Stem-Cell Gene Therapy","volume":"27","author":"Bernardo","year":"2016","journal-title":"Hum. Gene Ther."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:25:20Z","timestamp":1762421120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120302576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":81,"alternative-id":["S2329050120302576"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.12.009","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}